| New Data on Investigational Agent Belatacept in Kidney Transplant Recipients ... - Business Wire (press release) |
|
|
Business Wire (press release) “The breadth of Bristol-Myers Squibb's clinical data on belatacept at the American Transplant Congress demonstrates our ongoing commitment to address the unmet medical needs of patients in the renal transplant community.” Three-Year Outcomes from |